Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Nederlands Tijdschrift Voor Geneeskunde|May 4, 2019
[Maintenance treatment with macrolide antibiotics in COPD: not for everyone]Josje Altenburg, Joost G van den Aardweg
The Clinical Respiratory Journal|July 12, 2019
Aetiology and disease severity are among the determinants of quality of life in bronchiectasisLotte C Terpstra, Sonja Biesenbeek, Josje Altenburg, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|January 31, 2024
Eradication treatment for Pseudomonas aeruginosa infection in adults with bronchiectasis: a systematic review and meta-analysisMariana Conceição, Michal Shteinberg, Pieter Goeminne, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 17, 2024
Correlation between trough concentration and AUC for elexacaftor, tezacaftor and ivacaftorSteffie E M Vonk, Josje Altenburg, Ron A A Mathôt, et al.
ERJ Open Research|October 28, 2021
Anxiety and depression in Dutch patients with primary ciliary dyskinesia and their caregivers: associations with health-related quality of lifeMarieke Verkleij, Iris Appelman, Josje Altenburg, et al.
Medical Mycology Case Reports|January 29, 2024
Coccidioidomycosis presenting years after returning from travelKoos Korsten, Josje Altenburg, Marieke Gittelbauer, et al.
Pediatric Pulmonology|April 21, 2023
Depression, anxiety, and resilience during COVID-19 in Dutch patients with cystic fibrosis or primary ciliary dyskinesia and their caregiversLieke Noij, Eric Haarman, Simone Hashimoto, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|December 24, 2002
Seizure detection in the neonatal EEG with synchronization likelihoodJosje Altenburg, R Jeroen Vermeulen, Rob L M Strijers, et al.
The Clinical Respiratory Journal|August 9, 2014
Validation of a visual analogue score (LRTI-VAS) in non-CF bronchiectasisJosje Altenburg, Kim Wortel, Casper S de Graaff, et al.
Journal of Thoracic Disease|October 29, 2025
Patient Preferences in empYema treatment (PAPY-study): are we investigating relevant outcomes for patients?Weija R de Jonge, Josje Altenburg, Chris Dickhoff, et al.
Pageof 6